These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20196723)

  • 21. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
    Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
    Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA sequencing for research and diagnostics in clinical oncology.
    Buzdin A; Sorokin M; Garazha A; Glusker A; Aleshin A; Poddubskaya E; Sekacheva M; Kim E; Gaifullin N; Giese A; Seryakov A; Rumiantsev P; Moshkovskii S; Moiseev A
    Semin Cancer Biol; 2020 Feb; 60():311-323. PubMed ID: 31412295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.
    Verma M; Wright GL; Hanash SM; Gopal-Srivastava R; Srivastava S
    Ann N Y Acad Sci; 2001 Sep; 945():103-15. PubMed ID: 11708463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteome analysis and its impact on the discovery of serological tumor markers.
    Poon TC; Johnson PJ
    Clin Chim Acta; 2001 Nov; 313(1-2):231-9. PubMed ID: 11694264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of proteomic technologies to tumor analysis.
    Misek DE; Imafuku Y; Hanash SM
    Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
    Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
    Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
    Hariharan D; Weeks ME; Crnogorac-Jurcevic T
    Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating cancer genomics and proteomics in the post-genome era.
    Hanash SM; Bobek MP; Rickman DS; Williams T; Rouillard JM; Kuick R; Puravs E
    Proteomics; 2002 Jan; 2(1):69-75. PubMed ID: 11788993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
    Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of proteome profiling to the molecular analysis of cancer.
    Wang H; Hanash SM
    Technol Cancer Res Treat; 2002 Aug; 1(4):237-46. PubMed ID: 12625782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene arrays and proteomics. A primer.
    Moulédous L; Gutstein HB
    Methods Mol Med; 2003; 84():141-54. PubMed ID: 12703322
    [No Abstract]   [Full Text] [Related]  

  • 33. [Development of the new tumor markers].
    Terashima K
    Rinsho Byori; 2005 Mar; 53(3):234-8. PubMed ID: 15839053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomics--a new player in the post-genomic era.
    Maithal K
    Indian J Biochem Biophys; 2002 Oct; 39(5):291-302. PubMed ID: 22905374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics as a route to identification of toxicity targets in environmental toxicology.
    Dowling VA; Sheehan D
    Proteomics; 2006 Oct; 6(20):5597-604. PubMed ID: 16972288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomics in early detection of cancer.
    Srinivas PR; Srivastava S; Hanash S; Wright GL
    Clin Chem; 2001 Oct; 47(10):1901-11. PubMed ID: 11568117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic strategies for the characterization and the early detection of lung cancer.
    Massion PP; Caprioli RM
    J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease proteomics.
    Hanash S
    Nature; 2003 Mar; 422(6928):226-32. PubMed ID: 12634796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative Exploratory Analysis of Two or More Genomic Datasets.
    Meng C; Culhane A
    Methods Mol Biol; 2016; 1418():19-38. PubMed ID: 27008008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.